C-X-C Chemokine Receptor Type 4 (CXCR4) and Programmed Death-Ligand 1 (PD-L1) Expression are Prognostic Biomarkers for Papillary Thyroid Carcinoma

被引:0
|
作者
Ding, Ting [1 ]
Song, Qian [1 ]
Xu, Yanjun [2 ]
Liu, Qiya [3 ]
机构
[1] Huanggang Cent Hosp, Dept Endocrinol, Huanggang City 438021, Hubei, Peoples R China
[2] Zhejiang Univ Tradit Chinese Med, Dept Special Inspect Sect, Affiliated Hosp 3, Hangzhou 310014, Zhejiang, Peoples R China
[3] Sha He Hosp Chang Ping Dist Beijing, Dept Gen Med, Beijing 100005, Peoples R China
关键词
CXCR4; PD-L1; Papillary Thyroid Carcinoma; Survival Analysis; CANCER; SURVIVAL; NIVOLUMAB; ANTITUMOR; PATHWAY;
D O I
10.1166/jbt.2022.2987
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Chemokines and immunomodulatory factors involve in tumor development. Papillary thyroid carcinoma (PTC) is considered to start from dendritic cell infiltration and then produce immunomodulatory factors. In this study, CXCR4 and PD-L1 biomarkers were used to explore their prognostic role in PTC survival. Confocal microscopy detected the transfection efficiency in tumor cells. 42 PTC patients and thyroiditis patients (control) were enrolled to measure the expressions of CXCR4 and PD-L1. Multi-factor analysis analyzed the effect of combined CXCR4 and PD-L1 expression on ROC. The two groups had no differences in the baseline characteristics. CTXCR4 and PD-L1 level in PTC patients was significantly higher than control. CXCR4 was lowly expressed in thyroid cancer tissue and PD-L1 was highly expressed in serological samples. Compared with single measurement, the combined detection of CXCR4 and PD-L1 showed more ROC area. In conclusion, reduced CXCR4 and increased PD-L1 levelis found in thyroid cancer and their level might be used IP: 182.75.148.10 On: Thu, 20 Jan 2022 10:55:44 as predictive markers for PTtoCopyright:improve thAmeriancurative Scintificeffect. Publishers
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [21] Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma
    Ilaria Girolami
    Liron Pantanowitz
    Ozgur Mete
    Matteo Brunelli
    Stefano Marletta
    Chiara Colato
    Pierpaolo Trimboli
    Anna Crescenzi
    Massimo Bongiovanni
    Mattia Barbareschi
    Albino Eccher
    Endocrine Pathology, 2020, 31 : 291 - 300
  • [22] Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma
    Girolami, Ilaria
    Pantanowitz, Liron
    Mete, Ozgur
    Brunelli, Matteo
    Marletta, Stefano
    Colato, Chiara
    Trimboli, Pierpaolo
    Crescenzi, Anna
    Bongiovanni, Massimo
    Barbareschi, Mattia
    Eccher, Albino
    ENDOCRINE PATHOLOGY, 2020, 31 (03) : 291 - 300
  • [23] The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12
    Youssry, Sara
    Hussein, Amina
    Moaaz, Mai
    MICROBIOLOGY AND IMMUNOLOGY, 2021, 65 (09) : 392 - 399
  • [24] Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma
    Serra, Pierre
    Petat, Arthur
    Maury, Jean-Michel
    Thivolet-Bejui, Francoise
    Chalabreysse, Lara
    Barritault, Marc
    Ebran, Nathalie
    Milano, Gerard
    Girard, Nicolas
    Brevet, Marie
    LUNG CANCER, 2018, 118 : 62 - 68
  • [25] Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis
    Wu, Zhaoshu
    Cao, Yue
    Jiang, Xiaoyan
    Li, Min
    Wang, Gang
    Yang, Yue
    Lu, Kai
    MINERVA ENDOCRINOLOGICA, 2020, 45 (01) : 43 - 48
  • [26] Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer
    He, Hongyong
    Wang, Cong
    Shen, Zhenbin
    Fang, Yong
    Wang, Xuefei
    Chen, Weidong
    Liu, Fenglin
    Qin, Xinyu
    Sun, Yihong
    PLOS ONE, 2013, 8 (08):
  • [27] Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
    Song, Joon Seon
    Kim, Deokhoon
    Kwon, Ji Hyun
    Kim, Hyeong Ryul
    Choi, Chang-Min
    Jang, Se Jin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [28] The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
    Brinch, Charlotte Margareta
    Hogdall, Estrid
    Junker, Niels
    Moeller, Holger Jon
    Sandfeld-Paulsen, Birgitte
    de Heer, Pieter
    Penninga, Luit
    Rossen, Philip Blach
    Krarup-Hansen, Anders
    Aggerholm-Pedersen, Ninna
    CANCERS, 2022, 14 (23)
  • [29] Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1)
    Aisyah Izzatul Muna
    Maria Evata Krismawati Surya
    Meiske Margaretha
    Jane Kosasih
    Mei Syafriadi
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 3098 - 3102
  • [30] Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1)
    Muna, Aisyah Izzatul
    Surya, Maria Evata Krismawati
    Margaretha, Meiske
    Kosasih, Jane
    Syafriadi, Mei
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2023, 75 (04) : 3098 - 3102